Lamivudine And Zidovudine 71335-1916
Product NDC
71335-1916- Manufacturer
- Bryant Ranch Prepack
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 30, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA090679
Need to source Lamivudine And Zidovudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 150 mg/1 |
| Zidovudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(3)
6 TABLET in 1 BOTTLE (71335-1916-1)
60 TABLET in 1 BOTTLE (71335-1916-2)
4 TABLET in 1 BOTTLE (71335-1916-3)